InsideArbitrage Potential Deal Alert: Mural Oncology (MURA) Plans to Explore Strategic Alternatives
Mural Oncology (MURA) announced that following review of data from its phase 2 ARTISTRY-6 trial in melanoma and results from the phase 3 ARTISTRY-7 trial
Read More